These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1104 related articles for article (PubMed ID: 16169466)

  • 1. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.
    De Palma M; Venneri MA; Galli R; Sergi Sergi L; Politi LS; Sampaolesi M; Naldini L
    Cancer Cell; 2005 Sep; 8(3):211-26. PubMed ID: 16169466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells.
    De Palma M; Venneri MA; Roca C; Naldini L
    Nat Med; 2003 Jun; 9(6):789-95. PubMed ID: 12740570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.
    Coffelt SB; Tal AO; Scholz A; De Palma M; Patel S; Urbich C; Biswas SK; Murdoch C; Plate KH; Reiss Y; Lewis CE
    Cancer Res; 2010 Jul; 70(13):5270-80. PubMed ID: 20530679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.
    Venneri MA; De Palma M; Ponzoni M; Pucci F; Scielzo C; Zonari E; Mazzieri R; Doglioni C; Naldini L
    Blood; 2007 Jun; 109(12):5276-85. PubMed ID: 17327411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications.
    De Palma M; Murdoch C; Venneri MA; Naldini L; Lewis CE
    Trends Immunol; 2007 Dec; 28(12):519-24. PubMed ID: 17981504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships.
    Pucci F; Venneri MA; Biziato D; Nonis A; Moi D; Sica A; Di Serio C; Naldini L; De Palma M
    Blood; 2009 Jul; 114(4):901-14. PubMed ID: 19383967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis.
    De Palma M; Mazzieri R; Politi LS; Pucci F; Zonari E; Sitia G; Mazzoleni S; Moi D; Venneri MA; Indraccolo S; Falini A; Guidotti LG; Galli R; Naldini L
    Cancer Cell; 2008 Oct; 14(4):299-311. PubMed ID: 18835032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tie2-expressing monocytes (TEMs): novel targets and vehicles of anticancer therapy?
    De Palma M; Naldini L
    Biochim Biophys Acta; 2009 Aug; 1796(1):5-10. PubMed ID: 19362584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericyte-expressed Tie2 controls angiogenesis and vessel maturation.
    Teichert M; Milde L; Holm A; Stanicek L; Gengenbacher N; Savant S; Ruckdeschel T; Hasanov Z; Srivastava K; Hu J; Hertel S; Bartol A; Schlereth K; Augustin HG
    Nat Commun; 2017 Jul; 8():16106. PubMed ID: 28719590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tie2-dependent deletion of α6 integrin subunit in mice reduces tumor growth and angiogenesis.
    Bouvard C; Segaoula Z; De Arcangelis A; Galy-Fauroux I; Mauge L; Fischer AM; Georges-Labouesse E; Helley D
    Int J Oncol; 2014 Nov; 45(5):2058-64. PubMed ID: 25176420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.
    Piao Y; Park SY; Henry V; Smith BD; Tiao N; Flynn DL; de Groot JF
    Neuro Oncol; 2016 Sep; 18(9):1230-41. PubMed ID: 26965451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paracrine role of Tie-2-expressing monocytes in tumor angiogenesis.
    Ribatti D
    Stem Cells Dev; 2009 Jun; 18(5):703-6. PubMed ID: 19186995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature.
    Reddy K; Cao Y; Zhou Z; Yu L; Jia SF; Kleinerman ES
    Angiogenesis; 2008; 11(3):257-67. PubMed ID: 18344025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma: a pathogenic crosstalk between tumor cells and pericytes.
    Caspani EM; Crossley PH; Redondo-Garcia C; Martinez S
    PLoS One; 2014; 9(7):e101402. PubMed ID: 25032689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.
    Matsubara T; Kanto T; Kuroda S; Yoshio S; Higashitani K; Kakita N; Miyazaki M; Sakakibara M; Hiramatsu N; Kasahara A; Tomimaru Y; Tomokuni A; Nagano H; Hayashi N; Takehara T
    Hepatology; 2013 Apr; 57(4):1416-25. PubMed ID: 22815256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion.
    Coffelt SB; Chen YY; Muthana M; Welford AF; Tal AO; Scholz A; Plate KH; Reiss Y; Murdoch C; De Palma M; Lewis CE
    J Immunol; 2011 Apr; 186(7):4183-90. PubMed ID: 21368233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are TEMs Canceled? Questioning the Functional Relevance of Tie2-Expressing Macrophages.
    Zhang Y; Brekken RA
    Cancer Res; 2022 Apr; 82(7):1172-1173. PubMed ID: 35373288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone-marrow-derived endothelial precursor cells into brain tumors.
    Udani V; Santarelli J; Yung Y; Cheshier S; Andrews A; Kasad Z; Tse V
    Neurol Res; 2005 Dec; 27(8):801-6. PubMed ID: 16354539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas.
    Cortes-Santiago N; Hossain MB; Gabrusiewicz K; Fan X; Gumin J; Marini FC; Alonso MM; Lang F; Yung WK; Fueyo J; Gomez-Manzano C
    Oncotarget; 2016 Mar; 7(13):16146-57. PubMed ID: 26910374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche.
    Díaz-Flores L; Gutiérrez R; Madrid JF; Varela H; Valladares F; Acosta E; Martín-Vasallo P; Díaz-Flores L
    Histol Histopathol; 2009 Jul; 24(7):909-69. PubMed ID: 19475537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.